I'll ask everyone to take their seats now so that we can get started.
I want to welcome the witnesses today. This is the Subcommittee on Neurological Disease of the Standing Committee on Health. Pursuant to Standing Order 108(2), the study on neurological diseases will begin today.
In this particular area, we have with us Denise Figlewicz, vice-president of research with the ALS Society of Canada; we have Felicia Travis Valo; and we have Melanie York, who is a board member of the ALS Society of Canada.
Welcome. I'm very glad you could join us.
We also have Dr. Alex Parker, assistant professor from the Université de Montréal research centre. We're very pleased to have you here.
We'll have five-minute presentations, and we'll begin with Ms. Figlewicz.